3Brown M. The effect of HLA-DR genes on susceptibility to and severity of ankylosing spondylitis [J ]. Arthritis Rheum, 1998,41 (3) :460-465.
4Brown MA,Laval SH, Brophy S, et al. Recurrence risk modeling of the genetic susceptibility to ankylosing spondylitis[ J]. Ann Rheum Dis,2000,59( 11 ) :883-886.
5Laval SH, Timms A, Edwards S, et al. Whole-genome screening in ankylosing spondylitis: evidence of non-MHC genetic-susceptibility loci[J]. Am J Hum Genet, 2001,68(4) :918-926.
6Gonzalez S, Torre-Alonso JC, Martinez-Borra J, et al. TNF-238A promoter polymorphism contributes to susceptibility to ankylosing spondylitis in HLA-B27 negative patients [ J ]. J heumatol, 2001,28 (6) :1203-1206.
7Vargas-Alarcon G, Gamboa R, Zuniga J, et al. Association study of LMP gene polymorphisms in Mexican patients with spondyloarthritis [ J]. Hum Immuno1,2004,65 ( 12 ) : 1437-1442.
8Fraile A, Collado MD, Mataran L, ctal. TAP1 and TAP2 Polymorphism in Spanish patients with ankylosing spondylitis[ J]. Exp Clin Imm, 2000,17(4) :199-204.
9Ricci-Vitiani L, Vacca A, Potolicchio I, et al. MICA gene triplet repeat polymorphism in patients with HLA-B27 positive and negative ankylosing spondylitis from Sardinia [ J ]. J Rheumatol, 2000,27 (9) :93-97.
10Rueda B, Orozco G, Raya E,et al. The IL-23R Arg381Gln non- synonymous polymorphism confers susceptibility to ankylosing spondylitis [ J ]. Ann Rheum Dis, 2008,67 (10) : 1451-1454.
